Chun-Hyung Kim Selected Research

dopamine beta hydroxylase deficiency

3/2011	Norepinephrine deficiency is caused by combined abnormal mRNA processing and defective protein trafficking of dopamine beta-hydroxylase.
3/2002	Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chun-Hyung Kim Research Topics

Disease

9	Parkinson Disease (Parkinson's Disease) 01/2020 - 12/2009
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2010 - 12/2006
2	dopamine beta hydroxylase deficiency 03/2011 - 03/2002
1	Alopecia (Baldness) 11/2020
1	Autoimmune Diseases (Autoimmune Disease) 10/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Hyperthyroidism 01/2019
1	Diarrhea 04/2016
1	Neuroinflammatory Diseases 01/2016
1	Schizophrenia (Dementia Praecox) 08/2015
1	Bipolar Disorder (Manic Depressive Psychosis) 08/2015
1	Movement Disorders (Movement Disorder) 07/2015
1	Dyskinesias (Dyskinesia) 07/2015
1	Alzheimer Disease (Alzheimer's Disease) 01/2015
1	Genomic Instability 05/2014
1	Anhedonia 03/2014
1	Pre-Eclampsia (Preeclampsia) 03/2013
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 03/2011
1	Huntington Disease (Huntington's Disease) 12/2005
1	Pure Autonomic Failure 07/2003
1	Orthostatic Intolerance 07/2003
1	Autonomic Nervous System Diseases (Dysautonomia) 07/2003
1	Multiple System Atrophy 07/2003

Drug/Important Bio-Agent (IBA)

6	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 03/2011
4	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 03/2013 - 12/2006
3	Proteins (Proteins, Gene)FDA Link 01/2015 - 06/2011
3	Dopamine beta-HydroxylaseIBA 03/2011 - 03/2002
2	Neuroprotective AgentsIBA 01/2020 - 01/2016
2	Pharmaceutical PreparationsIBA 10/2019 - 01/2016
2	Oxidopamine (6 Hydroxydopamine)IBA 01/2016 - 07/2015
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2013 - 03/2011
1	Protein Isoforms (Isoforms)IBA 11/2020
1	Alprostadil (Muse)FDA LinkGeneric 01/2020
1	prostaglandin A1 (PGA1)IBA 01/2020
1	Chloroquine (Aralen)FDA LinkGeneric 10/2019
1	Antimalarials (Antimalarial Agents)IBA 10/2019
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 01/2019
1	Thyroid HormonesIBA 01/2019
1	Histidine (L-Histidine)FDA Link 04/2016
1	CarbohydratesIBA 04/2016
1	Diethyl Pyrocarbonate (Diethylpyrocarbonate)IBA 04/2016
1	OligosaccharidesIBA 04/2016
1	DiterpenesIBA 01/2016
1	Orphan Nuclear ReceptorsIBA 01/2016
1	LipopolysaccharidesIBA 01/2016
1	mezereinIBA 01/2016
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 07/2015
1	Amyloid beta-PeptidesIBA 01/2015
1	Member 2 Group A Nuclear Receptor Subfamily 4IBA 01/2015
1	Amyloid (Amyloid Fibrils)IBA 01/2015
1	Sucrose (Saccharose)IBA 03/2014
1	Messenger RNA (mRNA)IBA 03/2011
1	Mixed Function Oxygenases (Monooxygenases)IBA 03/2011
1	Neurotransmitter Agents (Neurotransmitter)IBA 03/2011
1	Epinephrine (Adrenaline)FDA LinkGeneric 03/2011
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 03/2010
1	Transcription Factors (Transcription Factor)IBA 12/2006
1	3-nitropropionic acidIBA 12/2005

Therapy/Procedure

3	Therapeutics 10/2019 - 12/2009
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017